Pure Global

Lyra SARS-CoV-2 Assay - India CDSCO Medical Device Registration

Lyra SARS-CoV-2 Assay is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000377_5563aa70a25eba004664fa36aaafdbca_8c8d176843a7350262834cf22838221a. This device is marketed under the brand name Lyra SARS-CoV-2 Assay. The license holder is M/s Parekh Integrated Services Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Lyra SARS-CoV-2 Assay
UID: IMP/IVD/2020/000377_5563aa70a25eba004664fa36aaafdbca_8c8d176843a7350262834cf22838221a

Brand Name

Lyra SARS-CoV-2 Assay

Device Class

Class C

Approving Authority

CDSCO

Product Information

The Lyra SARS-CoV-2 Assay is a real-time RT-PCR assay intended for the in vitro qualitative detection of nucleic acid from SARS CoV-2 in nasal, nasopharyngeal (Lyra SARS-CoV-2 Assay) or oropharyngeal (Lyra SARS-CoV-2 Assay) swab specimens from patients suspected of COVID-19 by their healthcare provider. The Assay targets the non-structural Polyprotein (Lyra SARS-CoV-2 Assay) of the SARS-CoV-2 virus. The authorized testing consists of nucleic acid extraction on the bioMerieux NucliSENSยฎ easyMAGยฎ system or EMAG system, followed by RT-PCR on the FDA-cleared real-time PCR Instrument

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing